Time: 13:11

Company News

Disappointing trial result for Sirtex

Disappointing news for Australian company Sirtex Medical (ASX:SRX) with the results of its 459-patient SARAH study confirming no survival benefit from use of its SIR-Spheres Y-90 resin microspheres over Bayer’s PBS-listed NEXAVAR (sorafenib). In the trial, patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres had … Continue reading Disappointing trial result for Sirtex

Starpharma triggers milestone payment from AZ

Australian company Starpharma has reached another milestone in its partnership with AstraZeneca covering development of its DEP drug delivery technology. The milestone has triggered a US$2 million milestone payment under Starpharma’s multiproduct DEP license. “This is the final preclinical milestone prior to advancing the first AZDEP candidate to clinical trials and follows the completion of extensive testing and scale up activities,” … Continue reading Starpharma triggers milestone payment from AZ

New Board appointments for Phylogica

Phylogica (ASX:PYC) has announced the appointment of Dr Robert Hayes and Dr Rick Kendall as Independent Non-Executive Directors of the company, with immediate effect. Mr Jeremy Curnock Cook has taken this opportunity to retire from the Board. Dr Robert Hayes was previously Head of Biologics at global biopharmaceutical company Amgen, responsible for the leadership, strategic direction and … Continue reading New Board appointments for Phylogica

Immuron announces positive results of IMM-124E in acute colitis

Immuron (ASX:IMC) has announced it has successfully completed the first stage of its colitis preclinical program at the University of Zurich in Switzerland. The company said it is preparing to move forward to the next development phase, in accordance with the research program. According to Immuron, IMM-124E showed a significant positive effect on all levels of … Continue reading Immuron announces positive results of IMM-124E in acute colitis

New alliance for Invion

Brisbane-based respiratory and autoimmune disease company Invion (ASX: IVX) has announced a a strategic alliance with Hong Kong-based The Cho Group. The Cho Group funds and has successfully commercialised a number of innovative technologies. According to Invion, the strategic alliance represents an opportunity to expand its business and develop its asset pipeline through the identification and in-licencing of new advanced … Continue reading New alliance for Invion

Extended deployment for Alcidion’s Patient Flow Solution

The Northern Territory Department of Health has extended their relationship with Alcidion (ASX:ALC) with deployment of the company’s Patient Flow Solution throughout Katherine Hospital. According to the company, its Miya platform provides all the data necessary to best manage patient care, from the reception of the patient (Emergency Department or elective admissions) through the hospital wards and … Continue reading Extended deployment for Alcidion’s Patient Flow Solution

IDT reports better than expected sales result

IDT Australia has reported better than expected sales following the recent US launch of its generic temozolomide. The company received FDA approval for its internally developed temozolomide brand in April 2016. Temozolomide is a cytotoxic drug used in the treatment of brain cancer. Mayne Pharma launched temozolomide in the US in November 2016 with one batch of each of 7 … Continue reading IDT reports better than expected sales result

Canadian launch for Starpharma’s VivaGel

Starpharma (ASX:SPL) has announced the launch of the VivaGel condom in Canada. The produce has been launched by Ansell under the LifeStyles Dual Protect brand. They carry the VivaGel brand and Starpharma says it will receive royalties based on sales.  According to the company, LifeStyles Dual Protect is the only condom of its type, providing barrier protection and incorporating the proprietary antiviral compound, astodrimer sodium (SPL7013, … Continue reading Canadian launch for Starpharma’s VivaGel